lotrafiban has been researched along with Cardiovascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, RC; Craft, RM; Liu, F; Morris, SA | 1 |
1 review(s) available for lotrafiban and Cardiovascular Diseases
| Article | Year |
|---|---|
Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker.
Topics: Animals; Benzodiazepines; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2000 |